| Target Price | CN¥68.06 |
| Price | CN¥98.46 |
| Deviation |
30.87%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Cansino Biologics Inc-h 2027 .
The average Cansino Biologics Inc-h target price is CN¥68.06.
This is
30.87%
register free of charge
CN¥70.07
28.84%
register free of charge
CN¥67.40
31.55%
register free of charge
|
|
| A rating was issued by 7 analysts: 6 Analysts recommend Cansino Biologics Inc-h to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Cansino Biologics Inc-h stock has an average upside potential 2027 of
30.87%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion CN¥ | 1.07 | 1.46 |
| 26.18% | 36.72% | |
| EBITDA Margin | 10.62% | 22.85% |
| 138.48% | 115.14% | |
| Net Margin | 2.61% | 9.08% |
| 105.83% | 247.92% |
2 Analysts have issued a sales forecast Cansino Biologics Inc-h 2026 . The average Cansino Biologics Inc-h sales estimate is
This results in the following potential growth metrics:
2 Cansino Biologics Inc-h Analysts have issued a net profit forecast 2026. The average Cansino Biologics Inc-h net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share CN¥ | 0.11 | 0.58 |
| 107.19% | 427.27% | |
| P/E | 171.03 | |
| EV/Sales | 10.01 |
2 Analysts have issued a Cansino Biologics Inc-h forecast for earnings per share. The average Cansino Biologics Inc-h EPS is
This results in the following potential growth metrics and future valuations:
Cansino Biologics Inc-h...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


